US FDA approves Adaptimmune’s gene therapy for rare type of cancer, ET HealthWorld

[Pelican Press 0]

This is the hidden content, please

• Sign In
• or
• Sign Up

US FDA approves Adaptimmune’s gene therapy for rare type of *******, ET HealthWorld

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

London: The U.S. Food and ***** Administration said on Friday it has approved Adaptimmune’s first-of-its-kind gene therapy to treat a rare type of ******* in the soft tissues, which typically affects young men.

Branded as Tecelra, it was approved to treat synovial sarcoma in certain patients who have received prior chemotherapy.

The company said the treatment would launch at a list price of $727,000.

It is the first gene therapy to be approved in the ******* States that uses a patient’s own immune response generating T-cells to ****** the *******.

Tecelra, administered as a single intravenous dose, was given an accelerated approval, which requires the company to verify its benefit in a confirmatory trial.

Synovial sarcoma, which most commonly develops in the extremities, impacts about 1,000 people in the ******* States each year and most often affects ****** males in their 30s or younger, according to the FDA.

Shares of the company fell 3.5 per cent to $1.23 in early trading.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)

• Published On Aug 3, 2024 at 06:44 AM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

Download ETHealthworld App

• Get Realtime updates
• Save your favourite articles

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

Scan to download App
data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

This is the hidden content, please

• Sign In
• or
• Sign Up

#FDA #approves #Adaptimmunes #gene #therapy #rare #type #******* #HealthWorld

This is the hidden content, please

• Sign In
• or
• Sign Up

This is the hidden content, please

• Sign In
• or
• Sign Up